Interestingly, tumors with TP53 mutation have a significantly shorter mPFS than tumors with wild-type TP53 (HR 0.17, P = 0.0008), consistent with findings that TP53 activation is essential to induce transcriptional dependency, rendering the cancer cells susceptible to CDK7 inhibition130. This evidence concerns the gene TP53 and cancer.